Microlearning Series
Cystic fibrosis has long been managed by treating its downstream effects, but a new generation of therapies is changing that. CFTR modulators target the root cause of CF at the cellular level, improving the function of the defective CFTR protein responsible for the disease itself.
This shift is especially significant in paediatric care, where early treatment has the potential to alter the long-term course of the disease, not just control its symptoms.
Advance your clinical approach in just minutes
This interactive, research-driven microlearning module walks through the cellular basis of cystic fibrosis, the different classes of CFTR modulators, potentiators and correctors, and how they work to restore protein function.
You’ll also explore the latest evidence on early treatment initiation and what it could mean for long-term outcomes in children with CF.
What you will explore
- Explain the pathophysiology of cystic fibrosis and the role of CFTR mutations in disease development.
- Describe the mechanisms of action of CFTR modulators, including potentiators and correctors.
- Summarize emerging therapeutic strategies for cystic fibrosis management in children.
